About NIPT
NIPT is an advanced technology that helps detect fatal chromosomal aneuploidies by analyzing the fetus' cell-free DNA. It also helps diagnose the risks for genetic disorders such as Down, Turner, Klinefelter, and XYY syndromes, which are common sex chromosomal aneuploidies associated with reproductive loss, infertility, and language development delays. Since its introduction into clinical practice in Hong Kong in 2011, NIPT has rapidly spread across the world.
Technavio’s analysts forecast the global non-invasive prenatal testing (NIPT) market to grow at a CAGR of 17.44% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global non-invasive prenatal testing (NIPT) market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of testing products.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Non-Invasive Prenatal Testing (NIPT) Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• BGI Genomics
• Illumina
• LifeCodexx
• Natera
• Sequenom
Other prominent vendors
• Ariosa Diagnostics
• Berry Genomics
• CombiMatrix
• F. Hoffmann-La Roche
• Genpharm Services
• Laboratory Corporation of America Holdings
• LifeLabs Genetics
• Quest Diagnostics
• Safembryo
• Sengenics
Market driver
• Incidence of fetal chromosomal disorders in newborns
• For a full, detailed list, view our report
Market challenge
• Limited consumer options and lack of effective product differentiation
• For a full, detailed list, view our report
Market trend
• Increase in partnerships and collaborations
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 06: Market segmentation by testing product
• Global NIPT market for MaterniT21 Plus test
• Global NIPT market for NIFTY test
• Global NIPT market for Harmony test
• Global NIPT market for Bambni test
• Global NIPT market for Verifi test
• Global NIPT market for Panorama test
• Global NIPT market for PrenaTest
PART 07: Market segmentation by end-user
• Hospitals
• Diagnostic clinical laboratories
• Research laboratories and academia
PART 08: Geographical segmentation
• NIPT market in Americas
• NIPT market in EMEA
• NIPT market in APAC
PART 09: Market drivers
• Child-bearing at advanced maternal age
• Incidence of fetal chromosomal disorders in newborns
• Advantages of NIPTs
PART 10: Impact of drivers
PART 11: Market challenges
• Pregnancy termination due to disability
• Limitations of prenatal cell-free DNA screening
• Limited consumer options and lack of effective product differentiation
PART 12: Impact of drivers and challenges
PART 13: Market trends
• Increased volumes of prenatal care counselling in hospitals
• Bioinformatics tools combined with DNA sequencing for NIPTs
• Increase in partnerships and collaborations
PART 14: Vendor landscape
• Competitive scenario
PART 15: Major vendors
• BGI Genomics
• Illumina
• LifeCodexx
• Natera
• Sequenom
• Other prominent vendors
PART 16: Appendix
• List of abbreviations
PART 17: Explore Technavio
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Global NIPT market ($ millions)
Exhibit 03: Five forces analysis
Exhibit 04: Global NIPT market segmentation by testing product 2015
Exhibit 05: Global NIPT market segmentation by testing product 2020
Exhibit 06: Global NIPT market for Maternit21 Plus test: Metric analysis 2016-2020
Exhibit 07: Global NIPT market for Maternit21 Plus test 2015-2020 ($ millions)
Exhibit 08: Global NIPT market for NIFTY test: Metric analysis 2016-2020
Exhibit 09: Global NIPT market for NIFTY test 2015-2020 ($ millions)
Exhibit 10: Global NIPT market for Harmony test: Metric analysis 2016-2020
Exhibit 11: Global NIPT market for Harmony test 2015-2020 ($ millions)
Exhibit 12: Global NIPT market for Bambni test: Metric analysis 2016-2020
Exhibit 13: Global NIPT market for Bambni test 2015-2020 ($ millions)
Exhibit 14: Sensitivity and specificity of Verifi test
Exhibit 15: Global NIPT market for Verifi test: Metric analysis 2016-2020
Exhibit 16: Global NIPT market for Verifi test 2015-2020 ($ millions)
Exhibit 17: Global NIPT market for Panorama test: Metric analysis 2016-2020
Exhibit 18: Global NIPT market for Panorama test 2015-2020 ($ millions)
Exhibit 19: Detection rate of Panorama test
Exhibit 20: Global NIPT market for PrenaTest: Metric analysis 2016-2020
Exhibit 21: Global NIPT market for PrenaTest 2015-2020 ($ millions)
Exhibit 22: Global NIPT market segmentation by geography 2015
Exhibit 23: Global NIPT market segmentation by geography 2020
Exhibit 24: NIPT market in Americas 2015-2020 ($ millions)
Exhibit 25: NIPT market in EMEA 2015-2020 ($ millions)
Exhibit 26: NIPT market in APAC 2015-2020 ($ millions)
Exhibit 27: Non-invasive and invasive prenatal tests
Exhibit 28: Impact of drivers
Exhibit 29: Impact of drivers and challenges
Exhibit 30: Global NIPT market: Competitive landscape analysis 2015
Exhibit 31: BGI Genomics: Metrics analysis
Exhibit 32: Illumina: Metrics analysis
Exhibit 33: LifeCodexx: Metrics analysis
Exhibit 34: Natera: Metrics analysis
Exhibit 35: Sequenom: Metrics analysis
Exhibit 36: Other prominent vendors
